Puma Biotechnology Income Before Tax History
| PBYI Stock | USD 6.12 -0.03 -0.49% |
Income Before Tax | First Reported 2007-12-31 | Previous Quarter 9.2 M | Current Value 17.1 M | Quarterly Volatility 3.1 B |
Macro event markers
Structural changes in Puma Biotechnology's business tend to show up in Income Before Tax over time. The most recent reading gains meaning when set against the full distribution of past values.
Latest Puma Biotechnology's Income Before Tax Growth Pattern
Puma Biotechnology shows a increasing Income Before Tax pattern over the data range. The gap between the latest 37.6 M and prior 35.8 M represents a 4.76% move. Inflection points in Puma Biotechnology's Income Before Tax often correspond to material business events or reporting changes.
| Income Before Tax | 10 Years Trend |
|
No forward-looking guarantees are expressed or implied by this data.
Income Before Tax |
| Timeline |
Income Before Tax Trend Statistics
| Arithmetic Mean | -74,160,752 | |
| Geometric Mean | 43,951,365 | |
| Coefficient Of Variation | -143.42 | |
| Mean Deviation | 81,601,969 | |
| Median | -54,659,000 | |
| Standard Deviation | 106,364,641 | |
| Sample Variance | 11313.4T | |
| Range | 329.6M | |
| R-Value | 0.42 | |
| Mean Square Error | 9984.4T | |
| R-Squared | 0.17 | |
| Significance | 0.1 | |
| Slope | 8,751,681 | |
| Total Sum of Squares | 181015T |
Puma Biotechnology Income Before Tax History
| 2026 | 37.6 M | ||
| 2025 | 35.8 M | ||
| 2024 | 24.1 M | ||
| 2023 | 22.7 M | ||
| 2022 | 457 K | ||
| 2021 | -28.8 M | ||
| 2020 | -59.8 M | ||
| 2019 | -75.5 M | ||
| 2018 | -113.6 M | ||
| 2017 | -292 M | ||
| 2016 | -276 M | ||
| 2015 | -239.3 M | ||
| 2014 | -142 M | ||
| 2013 | -54.7 M | ||
| 2012 | -74.3 M |
Related Accounts
| Last Reported | End Of Year Estimate | ||
| Accumulated Other Comprehensive Income | 36 K | 37.8 K | |
| Operating Income | 37.3 M | 39.2 M | |
| Income Before Tax | 35.8 M | 37.6 M | |
| Net Income | 31.1 M | 32.7 M | |
| Net Income From Continuing Ops | 31.1 M | 32.7 M | |
| Non Operating Income Net Other | -10.5 M | -10 M | |
| Total Other Income Expense Net | -1.5 M | -1.6 M | |
| Net Income Applicable To Common Shares | 2.3 K | 2.4 K | |
| Income Tax Expense | 4.7 M | 4.9 M | |
| Net Interest Income | -2.5 M | -2.7 M | |
| Interest Income | 4.1 M | 2.1 M | |
| Change To Netincome | 21.7 M | 20.6 M | |
| Net Income Per Share | 0.62 | 0.65 | |
| Income Quality | 1.34 | 1.41 | |
| Net Income Per E B T | 0.87 | 0.70 |
Methodology, Assumptions & Data Sources
Here is Puma Biotechnology's Income Before Tax over time. Checking other line items alongside this one sharpens the picture.
Unless otherwise specified, data for Puma Biotechnology is compiled from periodic company reporting and market reference feeds and standardized for comparability. Analyst inputs may be included when coverage is available. Updates may occur throughout the day. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.